Similar articles

• [Use of polyvinylpyridine N-oxide for treating experimental silicosis and anthracosilicosis].

  Deĭnega VG, Bolonova LN, Sukhanov VV, Zemliakova LF, Tkachuk SV. Deĭnega VG, et al. Gig Tr Prof Zabol. 1977;(6):25-8. Gig Tr Prof Zabol. 1977. PMID: 892540 Russian. No abstract available.
• [Effect of polyvinylpyridine N-oxide on pulmonary tissue scleroproteins in experimental silicosis].

  Gel'fon IA. Gel'fon IA. Gig Tr Prof Zabol. 1978 Sep;(9):54. Gig Tr Prof Zabol. 1978. PMID: 689462 Russian. No abstract available.
• [Polyvinylpyridine N-oxide (Bay 3504, P-204, PVNO) in the treatment of human silicosis].

  Prügger F, Mallner B, Schlipköter HW. Prügger F, et al. Wien Klin Wochenschr. 1984 Dec 7;96(23):848-53. Wien Klin Wochenschr. 1984. PMID: 6396971 Clinical Trial. German.
• [Trials of casual treatment of silicosis].

  Idec-Sadkowska I, Andrzejak R, Antonowicz-Juchniewicz J, Kaczmarek-Wdowiak B. Idec-Sadkowska I, et al. Med Pr. 2006;57(3):271-80. Med Pr. 2006. PMID: 17125034 Review. Polish.
• [Current aspects of treatment of silicosis].

  Sidorova NV. Sidorova NV. Sov Med. 1974 Aug;0(8):39-43. Sov Med. 1974. PMID: 4610803 Review. Russian. No abstract available.